Baird cuts target for Argenx stock to USD 823.00

Published on 10/13/2026 at 14:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Quarterly revenue reached USD 1.54 billion versus USD 1.45 billion consensus. Argenx stock costs EUR 736.40 on October 13, 2026.

Robert W. Baird lowered its Argenx target from USD 932.00 to USD 823.00 on October 9, 2026 and kept a Neutral rating.
Quarterly revenue was USD 1.54 billion against USD 1.45 billion consensus in the period reported July 21, 2026.
Argenx stock costs EUR 736.40 at Lang & Schwarz on October 13, 2026 at 2:01 p.m. CEST.
The stock has a 31.59 price-to-earnings ratio and a USD 50.5 billion market capitalization as of October 12, 2026.

Aquarellmalerei eines Lamas in grüner Andenlandschaft, weiche Pastellfarben in Salbei und Ocker, impressionistische Botanik, weißes Papiertextur sichtbar — Argenx NL0010832176 Lama als Symbol der Nanobody-Forschung in aquarellierter andiner Berglandschaft dargestellt, Illustration mit AI erstellt.

Robert W. Baird lowered its target for Argenx stock from USD 932.00 to USD 823.00 on October 9, 2026, while maintaining a Neutral rating, according to MarketBeat. Against the USD 812.30 primary-market price dated October 12, 2026, the new target stands 1.32 percent higher.

Quarterly revenue beats consensus

The same MarketBeat report said Argenx delivered USD 7.32 in earnings per share and USD 1.54 billion in quarterly revenue in the results released July 21, 2026. Revenue exceeded the USD 1.45 billion consensus estimate by USD 90.00 million, while earnings per share exceeded the USD 5.86 estimate by USD 1.46.

That result provides a concrete counterweight to the lower Baird target. The report also described a mixed pipeline, with positive Phase 2 data for FB102 in celiac disease alongside the discontinuation of a Phase 3 Vyvgart study in Sjögren's disease.

Stock stays inside its yearly range

Argenx's primary-market quote was USD 812.30 at 8:00 p.m. UTC on October 12, 2026, with 241,182 shares traded against an average volume of 318,017. The 52-week range was USD 661.85 to USD 1,072.75, placing the latest primary-market price USD 260.45 below the high and USD 150.45 above the low.

The current Lang & Schwarz price is EUR 736.40, so the euro quote and the primary-market dollar figures are separate market references. The company has a USD 50.5 billion market capitalization and a 31.59 price-to-earnings ratio based on the October 12, 2026 market snapshot.

Target cut resets valuation debate

Baird's move leaves its USD 823.00 target only 1.32 percent above the USD 812.30 primary-market price. MarketBeat also reported an average analyst target of USD 1,152.56 and a Moderate Buy consensus, but those figures reflect a wider group of analysts rather than Baird's Neutral view.